Why Are Insiders Buying Opko Health? $OPK

In the financial world, there are many reasons why corporate insiders would choose to sell their company’s stock, but only one reason why they would choose to buy.  Over the past decade, there has been a flood of empirical research – Lakonishok in 2001, Jeng and Metrick in 2003 – focused on determining the profitability of insider trading.

Opko Health Inc. (NYSE:OPK)

Interestingly enough, each study discovered a statistically significant relationship between insider purchases and abnormal returns, effectively throwing a wrench in the strong-form efficient market hypothesis.  When the dust settled, it was found that investors who mimic, or “monkey” insider buying behavior can beat the market by 6.4 percent per year, risk-adjusted.  Amidst seemingly never-ending Eurozone difficulties and plenty of headlines like this one floating around the blogosphere, any strategy that can consistently outperform the market should be welcomed with open arms.  So here’s a note to all insider monkeys out there: Opko Health (NYSE: OPK) has seen a rash of purchases lately, which are detailed below for your viewing pleasure.

Dr. Phillip Frost: With a name that sounds like he suits up as Mr. Freeze in the twilight hours of Gotham City, Dr. Frost has been quite the bull lately.  As the CEO and Chairman of the drug and medical device company, Frost is theoretically the best insider to follow, not to mention that his current net worth ($2.3B) exceeds Opko’s entire market value ($1.4B).  Since May, he has bought 2.23 million shares of OPK for a total value north of $10 million, increasing his total ownership of Opko to 37.3 percent.

Over this same time, the stock’s value has remained relatively flat, though the company has announced a key U.S. patent allowance of its “Flow Control in Microfluidic Systems” application.  While this sounds like medical gobbledygook, it essentially gives the company a way have a larger foothold in the point-of-care diagnostics market.  Anytime you have your cholesterol checked or glucose levels monitored, a POC device is most likely used (here’s a good way to visualize this technology).  Now, it’s estimated that the total size of the POC market will be worth $16.5 billion by 2016, up from $13.8 billion today.  So, it may be the combination of this macroeconomic tailwind with Opko’s newfound patent advantage that explains Frost’s bullishness.

Dr. Richard Lerner: Aside from the CEO, company director Richard Lerner has also bought shares of OPK over the past couple months, adding 50,000 shares at an average price of $4.60 each.  While this amount is much smaller than those of his superior, it does represent a larger portion of Lerner’s portfolio, as these transactions nearly doubled his total holdings of the stock.  Interestingly, Lerner has served as the President of the Scripps Research Institute, a nonprofit biomedical research institute with links to POC explorations.  If something big were on Opko’s horizon, Lerner would clearly have the expertise to understand the potential benefits of such a possibility.

From an investment standpoint, Opko has been a dud in 2012, losing 5.9 percent of its value.  The company has reported negative earnings in each of the past five years, though they are nearing profitability.  After having an EPS of -$0.13 in 2009, and -$0.08 in 2010, OPK almost broke even last year, reporting an earnings loss of 1 cent a share.  By the end of this year, the Street is still expecting a loss of 10 cents a share, so much is riding on the company’s next earnings release the second week of August.

Bulls will point to Opko’s $8.8 million in revenues in the first quarter of 2012, which was up 51.5 percent year-over-year, but this did underwhelm analyst expectations, who were forecasting a top line of $9.1 million.  Negative earnings makes traditional P/E analysis unusable, but it is notable that the stock is currently trading at a Price-to-Book ratio (8.8X) that is way above the industry average (2.3X), and competitors like Medtronic (NYSE: MDT) at 2.3X, Stryker Corp (NYSE: SYK) at 2.5X, and Waters Corp (NYSE: WAT) at 5.2X.  If Opko does warrant this high valuation, its POC patent may provide the dollars.  WealthLift’s Sentiment Index rates OPK as a hold, as users are mixed on what the future may hold for this drug and medical device company.  To read up on other trading ideas in this uncertain market environment, visit WealthLift INSIDER today.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Biggest Airports in the World

The 5 Most Gang Infested Cities In America

The 34 Smartest Countries in the World

The 10 Countries with the Highest Suicide Rates

The 10 Most Technologically Advanced Countries in the World

The 10 Safest Countries in the World to Live in Peace

The 10 Top Selling Smartphones in the World 2014

The 12 Biggest Shopping Centers in the World

The 10 Friendliest Countries in the World

Qihoo 360 Technology Co Ltd (QIHU), Actavis plc (ACT), Yahoo! Inc. (YHOO) Among 20 Long Ideas from Sohn Canada

The 10 Laziest Countries in the World

The 10 Most Polluted Countries in the World

The 10 Most Dangerous Cities in America 2014

The Top 10 Gold Producing Countries in the World

The 10 Tallest Buildings in the World

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!